BIOLARGO, INC.
BIOLARGO, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 2 | 4 | 4 | 5 | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 3 | |||||
Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 3 | 2 | 2 | 3 | 1 | |||||
Notes And Loans Receivable Net Current | - | - | - | - | 3 | - | - | - | - | - | - | - | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 3 | 5 | 5 | 6 | 9 | 7 | 7 | 7 | 7 | 7 | 6 | 5 | |||||
Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Finance Lease Right Of Use Asset | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Notes And Loans Receivable Net Noncurrent | - | - | - | - | - | 0 | 0 | - | - | - | 0 | - | |||||
Equity Method Investments | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 7 | 9 | 8 | 9 | 12 | 11 | 11 | 10 | 10 | 10 | 8 | 7 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | |||||
Long Term Debt Current | - | - | - | 0 | 0 | - | 1 | - | - | - | - | 0 | |||||
Contract With Customer Liability Current | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability | - | - | - | - | - | - | - | - | - | 1 | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | |||||
Finance Lease Liability Current | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Liabilities Current | 5 | 5 | 5 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | |||||
Long Term Debt Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Noncurrent | |||||||||||||||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Finance Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Liabilities Noncurrent | 5 | 4 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 9 | 9 | 7 | 6 | 6 | 5 | 4 | 4 | 4 | 5 | 4 | 3 | |||||
Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 164 | 165 | 165 | 165 | 161 | 158 | 158 | 157 | 154 | 156 | 154 | 153 | |||||
Retained Earnings Accumulated Deficit | -166 | -164 | -161 | -158 | -152 | -151 | -150 | -148 | -148 | -148 | -147 | -146 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Stockholders Equity | -3 | -0 | 4 | 7 | 6 | 8 | 6 | 6 | 6 | 5 | 7 | 4 | |||||
Minority Interest | -1 | -2 | -3 | -3 | -3 | -3 | -3 | -3 | -0 | -3 | -3 | -3 | |||||
Liabilities And Stockholders Equity | 7 | 9 | 8 | 9 | 12 | 11 | 11 | 10 | 10 | 10 | 8 | 7 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | |||||
Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 293 | - | |||||
Common Stock Shares Issued | 325 | 320 | 317 | 311 | 307 | 302 | 301 | 301 | 298 | 296 | 293 | 289 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.69% | -15.38% | -15.38% | - | - | - | - | - | - | - | - | - |
| 2025 | -8.33% | -16.67% | -25.00% | 22.22% | -5.56% | -11.11% | 18.75% | 18.75% | 12.50% | -11.11% | -16.67% | -16.67% |
| 2024 | -27.78% | -27.78% | -27.78% | 4.17% | 0.00% | -8.33% | 0.00% | 25.00% | 25.00% | -14.29% | -21.43% | -25.00% |
| 2023 | - | - | - | - | - | - | 6.25% | 12.50% | 37.50% | 2.94% | -8.82% | -20.59% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.73 | 1.10 | 1.01 | 1.67 | 2.25 | 2.14 | 2.70 | 2.31 | 2.36 | 2.11 | 2.35 | 2.70 | |||||
| Quick Ratio | 0.61 | 0.98 | 0.89 | 1.54 | 2.13 | 2.01 | 2.54 | 2.22 | 2.28 | 2.00 | 2.27 | 2.58 | |||||
| Working Capital | -1.27M | 513.00K | 51.00K | 2.32M | 5.11M | 3.85M | 4.49M | 4.19M | 4.10M | 3.77M | 3.65M | 2.95M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -3.44 | -46.80 | 4.45 | 0.90 | 1.06 | 0.71 | 0.74 | 0.72 | 0.71 | 0.91 | 0.95 | 0.71 | |||||
| Interest Coverage TTM | -22.51 | -25.51 | -27.51 | -30.39 | -22.73 | -32.71 | -50.95 | -80.89 | -93.27 | -88.47 | -50.33 | -60.11 | |||||
| Debt Ratio | 1.41 | 1.02 | 0.82 | 0.65 | 0.52 | 0.52 | 0.42 | 0.42 | 0.41 | 0.48 | 0.49 | 0.42 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.43 | 0.59 | 0.83 | 1.11 | 1.25 | 1.60 | 1.90 | 2.20 | 2.01 | 1.61 | 1.87 | 1.82 | |||||
| Days Sales Outstanding TTM | 109.94 | 160.61 | 88.91 | 67.07 | 49.86 | 74.86 | 59.33 | 46.00 | 34.09 | 53.08 | 54.85 | 42.84 | |||||
| Receivables Turnover TTM | 3.32 | 2.27 | 4.11 | 5.44 | 7.32 | 4.88 | 6.15 | 7.93 | 10.71 | 6.88 | 6.65 | 8.52 | |||||
Per Share Metrics | |||||||||||||||||
| Free Cash Flow Per Share TTM | -0.03 | -0.03 | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 39.93% | 42.35% | 43.86% | 46.55% | 45.40% | 43.56% | 44.17% | 44.31% | 47.03% | 49.74% | 50.32% | 50.47% | |||||
| Operating Profit Margin TTM | -443.97% | -288.67% | -191.31% | -115.35% | -45.14% | -33.34% | -24.36% | -20.12% | -24.96% | -36.73% | -37.45% | -50.11% | |||||
| Net Profit Margin TTM | -363.52% | -236.39% | -151.71% | -111.34% | -47.04% | -35.97% | -24.45% | -14.27% | -16.53% | -27.68% | -28.65% | -38.81% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -70.95% | -65.55% | -56.32% | -41.59% | -16.44% | 22.95% | 45.37% | 85.77% | 91.44% | 52.96% | 107.85% | 117.76% | |||||
| Net Income Growth (1Y) | 124.53% | 126.43% | 170.99% | 355.61% | 137.73% | 59.75% | 24.06% | -31.68% | -12.25% | 19.52% | -21.66% | -27.92% | |||||
| EPS Growth (1Y) | 112.09% | 114.05% | 163.19% | 343.09% | 132.43% | 56.06% | 19.00% | -34.53% | -15.65% | 14.00% | -26.50% | -32.25% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -2.38 | -3.84 | -4.69 | -4.37 | -9.63 | -14.40 | -13.03 | -26.18 | -27.72 | -28.09 | -13.87 | -12.67 | |||||
| P/B TTM | -12.93 | -272.68 | 36.21 | 7.98 | 10.51 | 11.09 | 9.35 | 11.56 | 13.08 | 20.01 | 11.57 | 12.82 | |||||
| P/S TTM | 8.65 | 9.09 | 7.12 | 4.86 | 4.53 | 5.18 | 3.19 | 3.74 | 4.58 | 7.78 | 3.97 | 4.92 | |||||
| Market Cap | 35.31M | 50.99M | 55.25M | 52.53M | 63.67M | 84.36M | 56.64M | 69.11M | 77.07M | 103.01M | 48.61M | 48.95M | |||||
| Enterprise Value | 33.12M | 47.21M | 51.73M | 48.45M | 60.69M | 82.22M | 54.10M | 65.41M | 72.49M | 98.96M | 45.36M | 46.27M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -10.32M | -9.38M | -8.30M | -8.62M | -7.48M | -5.52M | -3.21M | -1.29M | -508.00K | -1.84M | -2.37M | -2.32M | |||||
| Net Debt | -2.19M | -3.79M | -3.52M | -4.08M | -2.98M | -2.14M | -2.55M | -3.70M | -4.58M | -4.05M | -3.25M | -2.68M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
BIOLARGO, INC. (BLGO) — SEC Financial Statements & Analysis
BIOLARGO, INC. (BLGO) is a chemicals & allied products company, incorporated in DE. BIOLARGO, INC. trades on OTC as: BLGO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), BIOLARGO, INC. reported a -70.95% year-over-year revenue growth, a Gross Profit Margin of 39.93% (TTM), a Debt-to-Equity ratio of -3.44x, a Price-to-Sales (P/S) ratio of 8.65x (TTM), a Price-to-Book (P/B) ratio of -12.93x (TTM), at a market cap of $35.31M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -70.95%
- Gross Profit Margin TTM
- 39.93%
- Debt To Equity
- -3.44x
- P/S TTM
- 8.65x
- P/B TTM
- -12.93x
- Market Cap
- $35.31M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOLARGO, INC. in?
BIOLARGO, INC. (BLGO) operates in the Chemicals & Allied Products industry.
What is BLGO's market cap?
BIOLARGO, INC. (BLGO) has a market capitalization of $35.31M as of 2026-06-30.
What exchange does BLGO trade on?
BIOLARGO, INC. (BLGO) trades on the OTC.
Where is BIOLARGO, INC. incorporated?
BIOLARGO, INC. is incorporated in DE.